4//SEC Filing
DEXCOM INC 4
Accession 0001093557-17-000028
$DXCMCIK 0001093557operating
Filed
Feb 12, 7:00 PM ET
Accepted
Feb 13, 7:18 PM ET
Size
9.7 KB
Accession
0001093557-17-000028
Insider Transaction Report
Form 4
DEXCOM INCDXCM
VALDES JORGE A
SVP of Operations
Transactions
- Exercise/Conversion
Common Stock
2017-02-09$9.80/sh+7,000$68,600→ 79,334 total - Sale
Common Stock
2017-02-09$79.76/sh−7,000$558,316→ 72,334 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2017-02-09$79.76/sh−7,000$558,316→ 0 totalExercise: $9.80From: 2011-03-12Exp: 2020-03-12→ Common Stock (7,000 underlying)
Holdings
- 3,499(indirect: By Trust)
Common Stock
Footnotes (4)
- [F1]On November 4, 2016 Mr. Valdes adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Valdes. The shares set forth above were sold pursuant to the 10b5-1 Plan.
- [F2]This transaction was executed in multiple trades at prices ranging from $79.40 to $80.48. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
- [F3]Included in this number are 72,334 unvested restricted stock units, 38,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019, 22,500 of which were granted on March 8, 2015 and shall vest through March 8, 2018 and 11,834 of which were granted on March 8, 2014 and shall vest through March 8, 2017.
- [F4]Shares are held by the Valdes-Lopez-Calleja Family Trust U/A/D 05/18/2011, with respect to which the reporting person is a trustee.
Documents
Issuer
DEXCOM INC
CIK 0001093557
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001093557
Filing Metadata
- Form type
- 4
- Filed
- Feb 12, 7:00 PM ET
- Accepted
- Feb 13, 7:18 PM ET
- Size
- 9.7 KB